Did not become law. It stopped in the Senate's Judiciary Committee on May 2, 2017. The 2017–2018 session has ended.
2017–2018 Regular Session
Senate Bill 654
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
18 co-sponsors
Camera Bartolotta, Scott Martin, David G. Argall, John H. Eichelberger Jr., Mario M. Scavello, Thomas J. McGarrigle, Wayne Langerholc Jr., Stewart J. Greenleaf, Jay Costa, Mike Folmer, John C. Rafferty Jr., Mike Regan, Randy Vulakovich, James R. Brewster, Kim L. Ward, Patrick J. Stefano, Patrick M. Browne, Michele Brooks
Its course
May 2 to May 2, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the SenateMay 2 to May 2 · stopped0 days
JudiciaryMay 2 to May 2 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.